Anzeige
Mehr »
Samstag, 14.06.2025 - Börsentäglich über 12.000 News
Anleger aufgepasst: Weltbank setzt jetzt ein neues Signal für Investoren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DFJP | ISIN: US65345B2016 | Ticker-Symbol:
NASDAQ
13.06.25 | 22:00
1,150 US-Dollar
-4,56 % -0,055
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEXALIN TECHNOLOGY INC Chart 1 Jahr
5-Tage-Chart
NEXALIN TECHNOLOGY INC 5-Tage-Chart

Aktuelle News zur NEXALIN TECHNOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoNexalin Technology, Inc. - 8-K, Current Report3
NEXALIN TECHNOLOGY Aktie jetzt für 0€ handeln
30.05.RedChip Companies, Inc.: Nexalin and FatPipe Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV83ORLANDO, FL / ACCESS Newswire / May 30, 2025 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and FatPipe, Inc. (Nasdaq:FATN) on the RedChip Small Stocks, Big Money...
► Artikel lesen
28.05.Nexalin Technology, Inc.: Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on June 31
28.05.Nexalin Technology: EPS verfehlt Schätzungen um 0,02 $ - Umsatz besser als erwartet2
13.05.Nexalin Technology, Inc. - 10-Q, Quarterly Report2
06.05.Nexalin Technology, Inc.: Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering1
05.05.Nexalin Prices 3.85 Mln Public Offering At $1.30/shr; Stock Plunges In Pre-market1
05.05.Nexalin Technology slides after pricing $5M stock offering3
05.05.Nexalin Technology legt öffentliches Angebot bei 1,30 US-Dollar pro Aktie fest1
05.05.Nexalin Technology sets public offering at $1.30 per share1
05.05.Nexalin Technology, Inc.: Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock1
05.05.Nexalin Technology, Inc. - 8-K, Current Report1
01.05.Nexalin Technology, Inc.: Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback128HOUSTON, TX, May 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin"), today announced that it plans to submit a Q-Submission ("Q-Sub") to the U.S....
► Artikel lesen
24.04.Nexalin Technology, Inc.: Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia134HOUSTON, TX, April 24, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin") the leader in Deep Intracranial Frequency Stimulation (DIFS) of the brain...
► Artikel lesen
23.04.Nexalin Technology files $50M common stock offering1
23.04.Nexalin Technology, Inc.: Nexalin Technology Announces Completion of Phases One Through Five of its Virtual Clinic and Digital Ecosystem for HALO Clinical Research and Patient Management151HOUSTON, TX, April 23, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin"), the leader in Deep Intracranial Frequency Stimulation (DIFS) of the brain...
► Artikel lesen
21.04.Nexalin Technology, Inc.: Nexalin Technology Expresses Strong Support for Health Tech Investment Act to Advance Medicare Reimbursement for AI-Enabled Devices3
17.04.Nexalin Technology, Inc. - 8-K, Current Report1
14.04.Nexalin Technology, Inc.: Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS) Technology in Treating Substance Use Disorders2
02.04.Nexalin begins clinical trial for brain stimulation therapy2
Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1